Should I buy Lam Research Corporation (LRCX)?
Our current rating for LRCX is Sell, with a 87/100 confidence score and a moat assessment of 9/10. Lam Research Corporation looks meaningfully overvalued at $295 against a fair-value midpoint of $183, and the bull/base/bear distribution shows -19.6% bull / -55.0% bear over our base horizon.
What Sell means for LRCX today
A Sell rating is the output of the composite fair-value band ($133–$237) compared with the live price ($295), a 9/10 moat score, and a 87/100 confidence reading on the data quality and model convergence behind the fair-value range. We do not issue Buy / Strong Buy unless valuation is in the strong half of our six-factor decision overlay AND the risk profile is non-elevated; the rating is gated, not free-form.
LRCX is rated Sell at $295.16 versus the reconciled fair value midpoint of $183.48, implying -37.84% upside/downside. Confidence is separately disclosed at 87/100. The full report explains every input: discount rate, terminal growth, deceleration curve, scenario probabilities, and where the rating could change next.
Bull, base and bear over our base horizon
Bull case (probability 20%): target $237.30, return -19.6%. Base case (probability 60%): target $183.48, return -37.8%. Bear case (probability 20%): target $132.71, return -55.0%.
Probability weights are not symmetric. Lam Research Corporation is a mature compounder stock, so the deceleration curve, terminal P/E, and confidence in the bull tail are calibrated to that archetype. The probability-weighted expected value in the full report folds these three scenarios into a single asymmetric expected return — a more honest "should I buy?" signal than any single point estimate.
Risks to the thesis
The top kill-scenarios our latest report flags for Lam Research Corporation are: Prolonged Memory Downturn; Severe Export Controls; Advanced Packaging Share Loss. The single biggest risk is Prolonged Memory Downturn: Extended reduction in NAND and DRAM capex significantly depresses equipment sales and margins beyond modeled downcycle parameters.
The biggest opportunity is Consensus target of $310.47 relies on ungrounded perpetual multiple expansion. Position management in the full report converts the rating into concrete checkpoints — quarterly reassessment triggers and the metric thresholds that should change the size of the position rather than the position itself.
Bottom line
Our Sell rating with 87/100 confidence is research for educational purposes — not personalised investment advice and not a price call. Use the fair-value range and the bull/base/bear distribution to size a view; use the kill-scenarios and the earnings decision tree to define what would invalidate it.
For the full evidence — 14 sections, sensitivity grid, scorecard, and the data-provenance appendix — see the canonical report at /stocks/lrcx/analysis.
Frequently asked questions
Should I buy LRCX now?
Our current rating for LRCX is Sell with a 87/100 confidence score. LRCX is rated Sell at $295.16 versus the reconciled fair value midpoint of $183.48, implying -37.84% upside/downside. Confidence is separately disclosed at 87/100. This is research, not personalised investment advice.
What is the buy / hold / sell trigger for LRCX?
We do not issue Buy / Strong Buy unless valuation is in the strong half of the six-factor overlay and risk is non-elevated. The full report walks through the gating logic.
What return does the base case imply for LRCX?
The base case (probability 60%) targets $183.48 for an implied return of -37.8% over our base horizon.
What is the biggest risk to a long LRCX position?
Prolonged Memory Downturn: Extended reduction in NAND and DRAM capex significantly depresses equipment sales and margins beyond modeled downcycle parameters.
Research for educational purposes. Not personalised investment advice. See the full LRCX report for the canonical evidence.